Descubre las innovaciones presentadas en el 57º Congreso SEPAR 2024. El Dr. Alvar Agustí, Catedrático de la Cátedra De Salud Respiratoria de la UB moderó: Aire de debate. Novedades en EPOC 2024
Explore how systemic inflammation differs between brain-dead (DBD) and circulatory-dead (DCD) lung donors and its impact on primary graft dysfunction (PGD) and mortality in lung transplant recipients.
Explore the link between Preserved Ratio Impaired Spirometry (PRISm) and arterial stiffness, highlighting significant findings from the Austrian LEAD study. Learn how PRISm impacts cardiovascular health.
Artificial Intelligence in Respiratory Medicine GOLD Webinar · 6 de Mayo del 2024.
Discover the relationships between symptoms and lung function in asthma and COPD from the NOVELTY study, highlighting key spirometry measures and their impact.
Video completo de la Primera Edición de REPRIMARIA de 8 del Mayo 2024
The efficacy and safety of mepolizumab in patients with COPD has been investigated in two placebo-controlled Phase 3 trials, METREX and METREO, and theongoing MATINEE trial.
This article examines exacerbations of COPD, emphasizing the need for identifying distinct etioendophenotypes to develop targeted therapies and improve current modest outcomes.
Durante la jornada RESPrimaria se destacó la importancia de la prevención y el diagnóstico precoz en la lucha contra estas patologías.
Más de 900 sanitarios se reunirán de forma presencial y online, este miércoles en Barcelona, para mejorar la prevención y el tratamiento de las
patologías respiratorias.
